Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RASAGILINE | 0.5MG | TABLET | Actual shortage | 2025-10-16 | 2025-12-04 | 269690 |
| TEVA-RISEDRONATE | 150MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1607 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2018-03-16 | 2018-07-30 | 43138 |
| TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2019-06-18 | 2019-07-16 | 86911 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2020-02-07 | 2020-04-09 | 105561 |
| TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2020-03-26 | 2020-04-09 | 109592 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2020-04-03 | 2020-04-09 | 110776 |
| TEVA-RISEDRONATE | 30MG | TABLET | Resolved | 2021-10-21 | 2021-12-17 | 147714 |
| TEVA-RISEDRONATE | 35MG | TABLET | Resolved | 2022-06-03 | 2024-02-06 | 161973 |
| TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2022-06-30 | 2022-12-08 | 163948 |
| TEVA-RISEDRONATE | 150MG | TABLET | Resolved | 2022-06-30 | 2024-02-06 | 163957 |
| TEVA-RISEDRONATE | 30MG | TABLET | Resolved | 2024-01-18 | 2025-04-29 | 216497 |
| TEVA-RISEDRONATE | 5MG | TABLET | Resolved | 2025-05-30 | 2025-07-03 | 259017 |
| TEVA-RISPERIDONE | 0.5MG | TABLET | Resolved | 2017-03-13 | 2023-10-03 | 1566 |
| TEVA-RISPERIDONE | 1.0MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42601 |
| TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2020-03-06 | 2020-04-02 | 107978 |
| TEVA-RISPERIDONE | 4.0MG | TABLET | Resolved | 2020-03-06 | 2020-04-02 | 107981 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2020-06-04 | 2020-07-09 | 116672 |
| TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2021-05-20 | 2021-06-03 | 139743 |
| TEVA-RISPERIDONE | 4.0MG | TABLET | Resolved | 2021-05-20 | 2021-07-09 | 139746 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LAMOTRIGINE | 25MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81388 |
| TEVA-LAMOTRIGINE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258646 |
| TEVA-LAMOTRIGINE | 150MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258652 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-25 | 2025-04-25 | 255824 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-29 | 2025-04-29 | 256085 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258507 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258510 |
| TEVA-LATANOPROST | 50MCG | SOLUTION | Discontinued | 2020-07-10 | 2020-07-10 | 120009 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258625 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81298 |
| TEVA-LISINOPRIL (TYPE P) | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81400 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104257 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Discontinued | 2019-08-15 | 2019-08-15 | 91648 |
| TEVA-LISINOPRIL (TYPE Z) | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258694 |
| TEVA-LISINOPRIL (TYPE Z) | 5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258699 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81301 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 25MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81368 |